🇺🇸 Artrodar in United States
89 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 89
Most-reported reactions
- Pain — 15 reports (16.85%)
- Arthralgia — 13 reports (14.61%)
- Drug Ineffective — 10 reports (11.24%)
- Gait Disturbance — 9 reports (10.11%)
- Pain In Extremity — 9 reports (10.11%)
- Fall — 8 reports (8.99%)
- Loss Of Consciousness — 7 reports (7.87%)
- Acute Kidney Injury — 6 reports (6.74%)
- Anxiety — 6 reports (6.74%)
- Arthropathy — 6 reports (6.74%)
Other Other approved in United States
Frequently asked questions
Is Artrodar approved in United States?
Artrodar does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Artrodar in United States?
TRB Chemedica is the originator. The local marketing authorisation holder may differ — check the official source linked above.